Market revenue in 2023 | USD 69.6 million |
Market revenue in 2030 | USD 97.2 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.26% in 2023. Horizon Databook has segmented the Denmark crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of infectious diseases, flu, musculoskeletal pain, headache, cold, and other conditions is expected to boost the demand for paracetamol in the country. Moreover, increasing involvement of research & academic institutes in studying the cause of headaches and migraines and their impact on workability are expected to boost the market further.
For instance, in January 2022, a study by the University of Copenhagen concluded that people suffering from migraines and headaches had an overall reduced capacity to work. A better understanding of disease management and treatment knowledge may help workplaces improve the work efficiency of individuals with frequent headaches.
Moreover, the growing geriatric population is likely to increase the risk of infectious diseases and other healthcare issues, such as musculoskeletal pain, which is expected to boost the consumption of paracetamol & combination drugs to manage pain.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark crocin market , including forecasts for subscribers. This country databook contains high-level insights into Denmark crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account